Current research continues to investigate Cagrilintides pharmacology, receptor signaling, long-term safety profile, and potential applications across obesity, metabolic disorders, appetite regulation, and combination peptide therapies
It is used in many medical treatments including those for heart disease, glaucoma, Alzheimers, Parkinsons, liver disease and more
Butyrate has anti-inflammatory properties and serves as an epigenetic regulator by activating G-protein coupled receptors (GPR41 and GPR43) and inhibiting histone deacetylase activity (Du et al., 2024)
Additional investigations focusing on stability, selectivity, and performance in more complex biological systems will therefore be essential to determine their actual therapeutic relevance